One week after being fine, symptoms returned, and I just took a rapid test which is positive again.; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (One week after being fine, symptoms returned, and I just took a rapid test which is positive again.) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 treatment.    Concurrent medical conditions included Allergy.   On 25-Oct-2021 at 3:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient received dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 13-May-2022 at 12:00 PM, the patient experienced COVID-19 (One week after being fine, symptoms returned, and I just took a rapid test which is positive again.). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (One week after being fine, symptoms returned, and I just took a rapid test which is positive again.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2022, SARS-CoV-2 test: positive (Positive) Positive at 12:00. On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         No Concomitant product use was reported.  The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment.  The patient took Paxlovid day one of Covid symptoms and day one of positive PCR test. The symptoms resolved in 2-3 days. One week after being fine, the symptoms returned, and the patient just took a rapid test which was positive again.   Company comment- This spontaneous case concerns a 58-year-old female patient with no relevant medical history, who experienced the unexpected, non-serious adverse event of special interest COVID-19 (with a positive SARS-CoV-2 test) that occurred 6 months and 18 days after receiving the third dose of mRNA-1273 Vaccine.  The patient took paxlovid on the same day she had covid symptoms and tested positive in polymerase chain test. Her symptoms resolved in 2-3 days. However, after 1 week, the symptoms recurred and she again tested positive using a rapid test. Outcome of the events was not recovered at the time of this report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 58-year-old female patient with no relevant medical history, who experienced the unexpected, non-serious adverse event of special interest COVID-19 (with a positive SARS-CoV-2 test) that occurred 6 months and 18 days after receiving the third dose of mRNA-1273 Vaccine.  The patient took paxlovid on the same day she had covid symptoms and tested positive in polymerase chain test. Her symptoms resolved in 2-3 days. However, after 1 week, the symptoms recurred and she again tested positive using a rapid test. Outcome of the events was not recovered at the time of this report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.